In Transwell assay, findings showed that glioma cells had attenuated invasion ability following transfection with CKS2‐siRNA, whereas the capability was increased after being transfected with CKS2 overexpression vector in U251 and LN229 (p < 0.05, Figure 5A–B). Here, CKS2 is linked to glioma.